EAG Life Sciences

EAG Laboratories provides advanced analytical testing and consulting solutions across materials science, engineering sciences, agroscience and biopharmaceuticals. It supports pharmaceutical development with specialized expertise in complex material characterization and regulatory compliance studies[5][6][7].

The company has expanded capabilities in medical device testing—including ISO-accredited labs for biocompatibility—and offers end-to-end support for chemical regulatory submissions[9][6]. It operates globally with over 20 locations and serves thousands of clients in more than 50 countries[5][9].

Since its acquisition by Eurofins Scientific in 2017, it has further broadened its reach as part of one of the world’s largest scientific services networks[2][5].

No clinical results or drug pipeline exist as the company does not develop therapeutics.

EAG Laboratories ("Evans Analytical Group", now "Eurofins EAG") is a leading global contract research organization specializing in advanced materials characterization and analytical consulting across life sciences—including pharmaceuticals and medical devices—as well as agrosciences and high-tech industries. Acquired by Eurofins Scientific in late 2017 but still operating under the "EAG" name within the group structure. The company does not have its own drug development pipeline but plays a critical role supporting innovation through sophisticated laboratory analyses required throughout product lifecycles—from R&D to regulatory approval—for thousands of industry clients worldwide.[1][2][3][4][5]